臨床試験

C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.

NCT: NCT03311451 · ACTIVE_NOT_RECRUITING

NCT識別子NCT03311451

ステータスACTIVE_NOT_RECRUITING

開始日2023-01-16

完了2026-12-18

SponsorMerit Medical Systems, Inc. (INDUSTRY)

First posted2017-10-17

Last updated2026-05-22

概要

The primary objective is to determine the safety and efficacy of the C2 CryoBalloon 180 Ablation System ("CryoBalloon 180") used at decreasing doses in ablation naïve patients with low- or high-grade dysplastic Barrett's Esophagus (BE) or with residual BE after resection of dysplasia or early adenocarcinoma.

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。